Company
Korsana Biosciences
Building best-in-class therapeutics with the goal of reducing the burden of neurodegenerative diseases because patients and caregivers deserve better
- Status
- Mergedas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Korsana Biosciences
Claim, correct or request removal
Record updated 28 September 2026
About
Korsana was founded with the mission to advance precision-engineered therapies, designed to address some of the biggest unmet needs in medicine. We are committed to delivering better medicines to patients suffering from devastating neurodegenerative diseases, starting with Alzheimer’s disease.
Funding snapshot
- Total raised
- $380MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $380M2026-09-08
Funding rounds
- Private Placement
- $380M2026-09-08, Company stated
About the company
- Status notes
- Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million
Products
- Other
- KRSA-028
- Other
- THETA
Loading relationship preview